| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.006 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |